Pathological Microscopes Market Research Report - Global Forecast till 2023

Global Pathological Microscopes Market Research Report: Information by Type (Electron Microscope, Optical Microscope, Compound Microscope, Digital Microscope, Fluorescence Microscope and others), Application (Bodily Fluids, Tissue Scanning and others) and End User (Pathology and Diagnostic Laboratories, Hospitals & Clinics, Forensic Laboratories and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

ID: MRFR/HC/5850-CR | August 2019 | Region: Global | 105 pages

Market Overview

Global Pathological Microscopes Market is expected to register 4.50% CAGR and is anticipated to reach USD 523.20 Million by 2023. Pathological microscopes are used in diagnostic centers for the diagnosis of chronic and infectious diseases. More specifically, it is used to investigate cells and body fluids in your laboratory and assess the quantity, type, and characteristics of blood cells.

The increasing use of pathological microscopes in drug discovery, rising prevalence of chronic and infectious diseases, increasing automation in laboratories and growth in the number of public and private diagnostic centers are the major drivers propelling market growth. However, unfavorable reimbursement policies and high cost associated with microscopes constrain the growth of the market.

Market Dynamics

 Increasing use of pathological microscopes in drug discovery is expected to drive the growth of the market. The pharmaceutical industry is witnessing a rapid change in technology due to increasing research and development activities conducted by private as well as public partners. Majority of the players in the pharmaceutical market are investing huge money in the development of new drugs. With increasing research and development activities, the use and demand for advanced instruments such as pathological microscopes in the pharmaceutical industry are growing. Increasing pathological microscopes in drug discovery are the primary factors accelerating the growth of the market. According to the International Federation of Pharmaceutical Manufacturers & Associations, in 2015, the global pharmaceutical industry spent more than USD 149.8 billion on research and development activities Moreover, rising prevalence of chronic and infectious diseases and increasing automation in laboratories fueled the growth of the market. Additionally, growth in the number of public and private diagnostic centers are likely to support market growth. On the other hand, the high costs associated with microscopes and unfavorable reimbursement policies is anticipated to hamper the market growth.

Global Pathological Microscopes Market Size, by End User, 2017 (USD Million)  Pathological Microscopes Market

Source: MRFR Analysis


The global pathological microscopes market has been segmented into type, application, and end user. 

Based type, the global market has been segmented into electron microscope, optical microscope, compound microscope, digital microscope, fluorescence microscope, and others.

Based on application, the global market has been segmented into bodily fluids, tissue scanning, and others.

Based on end user, the global market has been segmented into pathology and diagnostic laboratories, hospitals & clinics, forensic laboratories, and others. The pathology and diagnostic laboratories segment accounted for a market value of USD 181.63 million in 2017.

Key Players

The prominent players in the global pathological microscopes market are Nikon Corporation (Japan), Leica Biosystems Nussloch GmbH(Germany), Olympus Corporation(Japan), ZEISS International(Germany), Sakura Finetek USA(US), Inc., Celestron, LLC.( US), Labomed(US), Inc., Hitachi High-Technologies Corporation(Japan), Bruker Corporation(US), and Euromex Microscopen BV (Netherlands).

Some of the key strategies followed by the players operating in the global pathological microscopes market were innovation, product development, acquisition, and expansion.

Asia-Pacific Pathological Microscopes Market Share, by Country, 2017 (%)  Pathological Microscopes Market

Source: MRFR Analysis

Regional Analysis

The global pathological microscopes market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is estimated to dominate the global pathological microscopes market during the forecast period. This is attributed to the rising number of academic institutes, developed healthcare infrastructure, and increasing research and development activities are driving the growth of the market in this region.

The market for pathological microscopes in Europe is expected to be the second-largest during the forecast period, owing to factors such as the support provided by government bodies for the healthcare sector, increasing research and development activities, and developments in the life science sector. Additionally, the companies operating in the market are mainly focusing on mergers and acquisition, which is expected to support market growth.

Asia-Pacific is estimated to be the fastest-growing market due to the developing healthcare infrastructure and increasing disposable income. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in the region, Japan accounted for a market share of 23% in 2017.

Furthermore, the market in the Middle East & Africa is expected to witness limited growth due to the limited access to healthcare facilities.

Key Updates

  • In August 2018, Nikon Corporation announced the launch of the A1R HD25 confocal microscope. This microscope comes with high resolution and high-throughput and is known as the world's largest 25 mm field of view confocal microscope.

  • In June 2018, Olympus Corporation announced the partnership with MedTech innovator to improve clinical outcomes and reduce the overall cost with improved quality.

  • In March 2017, Hitachi High-Technologies Corporation opened Hitachi High-Tech Science Park Shanghai Lab in Shanghai. This helped the company develop and sell analytical instruments in the Chinese market.

Market Segmentation

Global Pathological Microscopes Market, by Type

  • Electron Microscope

  • Optical Microscope

  • Compound Microscope

  • Digital Microscope

  • Fluorescence Microscope

  • Others

Global Pathological Microscopes Market, by Application

  • Bodily Fluids

  • Tissue Scanning

  • Others

Global Pathological Microscopes Market, by End User

  • Pathology & Diagnostic laboratories

  • Hospitals & Clinics

  • Forensic Laboratories

  • Others

Global Pathological Microscopes Market, by Region

  • Americas

    • North America

      • US

      • Canada

    • Latin America

  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa

Available Additional Customizations

  • Additional Companies

    • Motic


    • Hirox

    • Jeol

    • Vision Engineering

  • Pricing Analysis

Intended Audience

  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies

Frequently Asked Questions (FAQ) :

Pathological microscopes market projected to grow at approximately 4.50% CAGR during the assessment period (2017-2023).

The valuation of the global pathological microscopes market is estimated to increase to USD 523.20 MN by the end of 2023.

Growth in the drug discovery and development sector and streamlined workflow are major tailwinds pushing the growth of the global pathological microscopes market.

North America holds the largest share in the global pathological microscopes market, followed by Europe and the Asia Pacific, respectively.

Sakura Finetek USA, Inc. (U.S.), Hitachi High-Technologies Corporation (Japan), Leica Biosystems Nussloch GmbH (Germany), Euromex Microscopen BV (The Netherlands), ZEISS International (Germany), Celestron LLC (U.S.), Labomed, Inc. (U.S.), Olympus Corporation (Japan), Bruker Corporation (U.S.), and Nikon Corporation (Japan), are some of the top players operating in the global pathological microscopes market.

Global Pathological Microscopes Market - Summary


Pathology concerns itself with the study of diseases via cell, tissue, and blood samples. The evolution of virus and disease strains calls for the need of advanced technological solutions. Pathological microscopes are used to identify or discern the presence of chronic or infectious diseases in the body by pathologists. The global pathological microscopes market is set to touch a valuation of USD 523.20 million by 2023. It can accrue significant revenue at 4.50% CAGR over the forecast period (2018-2023).

The emphasis on drug discovery and development by pharmaceutical companies is likely to trigger the demand for advanced microscopic devices. Pathological microscopes which discern the strength of drugs and vaccines against virulent strains will be in high demand till 2023. Rising prevalence of chronic diseases is predicted to drive the pathological microscopes market. This is evident by the high volume of patients visiting diagnostic centers. According to the Center for Disease Control & Prevention (CDC) in 2016, close to 16.8 million visited physicians.

Automation of laboratory processes to accelerate the diagnosis rate is likely to open up new opportunities for the market. The setup of various public and private diagnostic units to alleviate the burden of patient volume can bolster the pathological microscopes market till 2023.

Upcoming sectors of telemedicine and telepathology which reduces the diagnosis period of assays can pave open new growth avenues for the market. These sectors can use a mix of advanced processes and provide outcomes in real-time.


Types of microscopes include optical microscope, compound microscope, digital microscope, fluorescence microscope, electron microscope, and others. Electron microscopes had accounted for a major market share in 2017 thanks to its capacity to magnify the resolution of samples by 300 million. Its increased application in life sciences is likely to boost its segment exponentially by 2023. But digital microscopes are expected to take the lead as the most vouched instrument owing to the image sample being viewed clearly without any external devices. Development of new microscopy techniques, advances in digital cameras, and novel printing techniques are factors which can drive its phenomenal growth in the pathological microscopes market.

Major applications of these devices include tissue scanning, bodily fluids, and others. Bodily fluids accounted for the lion’s share in the pathological microscopes market owing to blood samples being a highly trusted source for discerning the presence of comorbidities. They are being used to detect blood-related disorders such as leukemia at an early stage. On the other hand, tissue scanning is the second-most effective method by detecting small ruptures in appendix and fallopian tubes. High incidence of cancer is ensured to drive its demand in the pathological microscopes market.

End-users include pathology & diagnostic laboratories, forensic laboratories, hospitals & clinics, and others. Pathology & diagnostic laboratories can contribute to the market thanks to possessing an arsenal of advanced equipment and skilled personnel. Hospitals and clinics are touted to be the biggest end-user of the pathological microscopes market owing to their ability to handle high patient volume.

Regional Analysis:

Geographic segmentation of the pathological microscopes market reveals details regarding Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas are likely to reign supreme in the pathological microscopes market owing to increasing funding in research and development activities. High prevalence of chronic diseases and discovery of novel drugs to treat rapidly evolving comorbidities is likely to propel the demand for microscopes in the region.

The APAC pathological microscopes market is projected to grow at a rapid pace thanks to a surplus of clinical researchers, boom in life sciences, and inflow of capital by firms to expedite drug discovery and development. On the other hand, Europe can experience a modest growth rate owing to increasing research and development (R&D) activities and support by government bodies in terms of funding.

Competitive Landscape:

Major players in the pathological microscopes market include Labomed, Inc. (U.S.), Nikon Corporation (Japan), Celestron LLC (U.S.), Olympus Corporation (Japan), Sakura Finetek USA, Inc. (U.S.), Bruker Corporation (U.S.), Hitachi High-Technologies Corporation (Japan), ZEISS International (Germany), Euromex Microscopen BV (The Netherlands), and Leica Biosystems Nussloch GmbH (Germany).

1.1          Company Market Share Analysis

1.1.1      Introduction

Numerous players are operating in the global pathology microscopes market. Some of the big players have captured a significant share in the global market, taking advantage of their strong position and presence in the number of countries and regions across the world. In the global pathology microscopes market, major companies are opting for new product launches, strategic partnerships, and collaboration to strengthen their market position.



Source: MRFR Analysis

The top players in the global pathology microscopes market are Olympus Corporation, Nikon Corporation, and Leica Biosystems Nussloch GmbH.

Olympus Corporation accounted for 55% of the global pathology microscopes market share in 2017. It is a market leader in global pathology microscopes market. The company operates in business segments including medical business, scientific solutions business, imaging business, and others. The company emphasizes on providing top quality products with advance technology. Olympus Corporation is expanding its portfolio by acquiring other market players. for instance, In May 2017 , the company has acquired Image Stream Medical, Inc. for USD 87 million.

Leica Biosystems Nussloch GmbH accounted for the second-largest market share of 20.3% in 2017. It operates as a subsidiary of Danaher Corporation. The company has strong presence in global pathology microscopes market. The company has six major plants all over the world and  present in more than 100 countries. Leica biosystems has strong distribution network in all the major markets. strategic partnerships, collaborations and new product launches are playing important role in development of the company. For instance, in October 2017, the company has signed distribution partnership with Polytech Domilens to strengthen its position in microscopes market of Germany.

Nikon Corporation operates in following segments imaging products business, precision equipment business, healthcare business, industrial metrology and others. The company accounted for 13.9% of the total market share in 2017. The company is launching new products to capture the untapped markets. Nikon corporation is present in more than 70 countries and 300 locations all over the world and has strong brand name in instruments market.

Some other major players operating in the Global Pathological Microscopes Market are  Sakura Finetek USA, Inc., Celestron, LLC., Labomed, Inc., Hitachi High-Technologies Corporation, Bruker Corporation, Euromex Microscopen bv and others.